Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000633425 | SCV000754649 | uncertain significance | Autosomal recessive polycystic kidney disease | 2017-10-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with PKHD1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with serine at codon 2342 of the PKHD1 protein (p.Gly2342Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. |
Natera, |
RCV000633425 | SCV002078032 | uncertain significance | Autosomal recessive polycystic kidney disease | 2018-06-08 | no assertion criteria provided | clinical testing |